Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 80:
81. The compound of claim 79, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2f is C3-C8 cycloalkyl, wherein the C3-C8 cycloalkyl is substituted by 1, 2, 3, 4, or 5 independently selected R2i substituents; and
each R2i is independently halogen, C1-C6alkyl, C2-C6 alkynyl, C6-C14 aryl, or 5- to 10-membered heteroaryl, wherein each C1-C6 alkyl, C2-C6 alkynyl, C6-C14 aryl, and 5- to 10-membered heteroaryl is optionally and independently substituted by 1, 2, 3, 4, or 5 independently selected R4a substituents; and
each R4a is C1-C6 alkyl or C6-C14 aryl.